The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Significant advances have been made over the past 25 years in our understanding of the most common adult solid tumors such as breast, colon, lung and prostate cancer. Much less is known about childhood solid tumors because they are rare and because they originate in developing organs during fetal development, childhood and adolescence. It can be very difficult to study the cellular origins of pediatric solid tumors in developing organs characterized by rapid proliferative expansion, growth factor signaling, developmental angiogenesis, programmed cell death, tissue reorganization and cell migration. Not only has the etiology of pediatric cancer remained elusive because of their developmental origins, but it also makes it more difficult to treat. Molecular targeted therapeutics that alter developmental pathway signaling may have devastating effects on normal organ development. Therefore, basic research focused on the mechanisms of development provides an essential foundation for pediatric solid tumor translational research. In this article, we describe new resources available for the developmental biology and oncology research communities. In a companion paper, we present the detailed characterization of an orthotopic xenograft of a pediatric solid tumor derived from sympathoadrenal lineage during development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
Activating mutations in ALK provide a therapeutic target in neuroblastoma
George, R. E., Sanda, T., Hanna, M., Fröhling, S., II, W. L., Zhang, J., Ahn, Y., Zhou, W., London, W. B., McGrady, P., et al. (2008) · Nature · doi:10.1038/nature07397 · Cited by 893
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752 · cited 11×
“For osteosarcoma, there were 50 tumor samples from 40 patients for WGS and 2 tumor samples from 2 patients for WES (Chen et al., 2014).”
MethodInfluentialSelf-citationKleinerman, R. A., Tucker, M. A., Tarone, R. E., Abramson, D. H., Seddon, J. M., Stovall, M., Li, F. P., & Fraumeni, J. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.054 · Cited by 487
Rb regulates proliferation and rod photoreceptor development in the mouse retina
Zhang, J., Gray, J., Wu, L., Leone, G., Rowan, S., Cepko, C. L., Zhu, X., Craft, C. M., & Dyer, M. A. (2004) · Nature Genetics · doi:10.1038/ng1318 · Cited by 190
Self-citationThe search for the retinoblastoma cell of origin
Dyer, M. A., & Bremner, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1545 · Cited by 170 · cited 2×
“The RB1 gene is a tumor suppressor that regulates the cell cycle, differentiation, and epigenetic processes (Dyer and Bremner, 2005; Macpherson and Dyer, 2007; Dyer, in press).”
Self-citation
Research works printed but not linked: 54
- Abramson, 1979, Second tumors in nonirradiated bilateral retinoblastoma, Am. J. Ophthalmol., 87, 624, 10.1016/0002-9394(79)90293-9 · DOI
- Applebaum, 2011, Clinical features and outcomes in patients with extraskeletal Ewing sarcoma, Cancer, 117, 3027, 10.1002/cncr.25840 · doi:10.1002/cncr.25840
- Barr, 1997, Chromosomal translocations involving paired box transcription factors in human cancer, Int. J. Biochem. Cell Biol., 29, 1449, 10.1016/S1357-2725(97)00095-2 · DOI
- Benavente, 2013, Cross-species genomic and epigenomic landscape of retinoblastoma, Oncotarget, 4, 844, 10.18632/oncotarget.1051 · DOI
- Brodeur, 2003, Neuroblastoma: biological insights into a clinical enigma, Nat. Rev. Cancer, 3, 203, 10.1038/nrc1014 · DOI · Paper page
- Cepko, 1996, Cell fate determination in the vertebrate retina, Proc. Natl. Acad. Sci. USA, 93, 589, 10.1073/pnas.93.2.589 · DOI · Paper page
- Chen, 2013, Targeting oxidative stress in embryonal rhabdomyosarcoma, Cancer Cell, 24, 710, 10.1016/j.ccr.2013.11.002 · DOI · Paper page
- Chen, 2015, Pediatric solid tumor genomics and developmental pliancy, Oncogene, 10.1038/onc.2014.474 · DOI
- Chen, 2008, Oncogenic mutations of ALK kinase in neuroblastoma, Nature, 455, 971, 10.1038/nature07399 · DOI · Paper page
- Cheung, 2012, Association of age at diagnosis and genetic mutations in patients with neuroblastoma, J. Am. Med. Assoc., 307, 1062, 10.1001/jama.2012.228 · DOI · Paper page
- Cheung, 2013, Neuroblastoma: developmental biology, cancer genomics and immunotherapy, Nat. Rev. Cancer, 13, 397, 10.1038/nrc3526 · DOI · Paper page
- Chow, 1971, Receptive field characteristics of striate cortical neurons in the rabbit, Brain Res., 33, 337, 10.1016/0006-8993(71)90107-7 · DOI
- Downing, 2012, The pediatric cancer genome project, Nat. Genet., 44, 619, 10.1038/ng.2287 · DOI · Paper page
- Dyer, M., 2015. In: Chalupa, L., Williams R., (Eds.), Eye, Retina, and Visual System of the Mouse, MIT Press, in press
- Finegold, 2007, Protocol for the examination of specimens from pediatric patients with hepatoblastoma, Arch. Pathol. Lab. Med., 131, 520, 10.5858/2007-131-520-PFTEOS · doi:10.5858/2007-131-520-pfteos
- Hatley, 2012, A mouse model of rhabdomyosarcoma originating from the adipocyte lineage, Cancer Cell, 22, 536, 10.1016/j.ccr.2012.09.004 · DOI
- Hicks, 2007, Clinicopathologic features of osteosarcoma in patients with Rothmund–Thomson syndrome, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 25, 370, 10.1200/JCO.2006.08.4558 · DOI
- Johnson, 2007, Neuronal differentiation and synaptogenesis in retinoblastoma, Cancer Res., 67, 2701, 10.1158/0008-5472.CAN-06-3754 · DOI
- Lessnick, 2012, Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets, Annu. Rev. Pathol., 7, 145, 10.1146/annurev-pathol-011110-130237 · DOI · Paper page
- London, 2005, Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 23, 6459, 10.1200/JCO.2005.05.571 · DOI · Paper page
- Lopez-Terrada, 2009, Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors, Hum. Pathol., 40, 783, 10.1016/j.humpath.2008.07.022 · DOI · Paper page
- Lu, 2015, The genomic landscape of childhood and adolescent melanoma, J. Investig. Dermatol., 10.1038/jid.2014.425 · DOI · Paper page
- Macpherson, 2007, Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy, Cancer Res., 67, 7547, 10.1158/0008-5472.CAN-07-0276 · DOI
- McEvoy, 2011, Coexpression of normally incompatible developmental pathways in retinoblastoma genesis, Cancer Cell, 20, 260, 10.1016/j.ccr.2011.07.005 · DOI
- McEvoy, 2015, RB1 inactivation by chromothripsis in human retinoblastoma, Oncotarget
- McIntyre, 1994, Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 12, 925, 10.1200/JCO.1994.12.5.925 · DOI · Paper page
- Meyers, 1993, Osteogenic sarcoma with clinically detectable metastasis at initial presentation, J. Clin. Oncol., 11, 449, 10.1200/JCO.1993.11.3.449 · DOI · Paper page
- Miller, 1990, Frequency and structure of p53 rearrangements in human osteosarcoma, Cancer Res., 50, 7950
- Missiaglia, 2012, PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification, J. Clin. Oncol., 30, 1670, 10.1200/JCO.2011.38.5591 · DOI · Paper page
- Molenaar, 2012, LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression, Nat. Genet., 44, 1199, 10.1038/ng.2436 · DOI · Paper page
- Mosse, 2004, Germline PHOX2B mutation in hereditary neuroblastoma, Am. J. Hum. Genet., 75, 727, 10.1086/424530 · DOI · Paper page
- Mosse, 2014, Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project, Pediatr. Blood Cancer, 61, 627, 10.1002/pbc.24777 · DOI
- Newton, 1988, Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 6, 67, 10.1200/JCO.1988.6.1.67 · DOI · Paper page
- Ognjanovic, 2009, Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975–2005, Cancer, 115, 4218, 10.1002/cncr.24465 · DOI · Paper page
- Pappo, 2003, Melanoma in children and adolescents, Eur. J. Cancer, 39, 2651, 10.1016/j.ejca.2003.06.001 · DOI · Paper page
- Perilongo, 1999, Liver tumours, Eur. J. Cancer, 35, 953, 10.1016/S0959-8049(99)00049-0 · DOI
- Raabe, 2008, Prevalence and functional consequence of PHOX2B mutations in neuroblastoma, Oncogene, 27, 469, 10.1038/sj.onc.1210659 · DOI
- Raney, 2001, Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V, J. Pediatr. Hematol. Oncol., 23, 215, 10.1097/00043426-200105000-00008 · DOI · Paper page
- Sausen, 2013, Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma, Nat. Genet., 45, 12, 10.1038/ng.2493 · DOI · Paper page
- Schulte, 2012, MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells, Oncogene, 32, 1059, 10.1038/onc.2012.106 · DOI
- Scrable, 1989, A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting, Proc. Natl. Acad. Sci. USA, 86, 7480, 10.1073/pnas.86.19.7480 · DOI · Paper page
- Sherr, 2001, The INK4a/ARF network in tumour suppression, Nat. Rev. Mol. Cell Biol., 2, 731, 10.1038/35096061 · DOI · Paper page
- Spector, 2012, The epidemiology of hepatoblastoma, Pediatr. Blood Cancer, 59, 776, 10.1002/pbc.24215 · DOI · Paper page
- Stahl, 2011, Risk of recurrence and survival after relapse in patients with Ewing sarcoma, Pediatr. Blood Cancer, 57, 549, 10.1002/pbc.23040 · DOI · Paper page
- Strouse, 2005, Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database, J. Clin. Oncol., 23, 4735, 10.1200/JCO.2005.02.899 · DOI · Paper page
- Tirode, 2015, Co-association between STAG2 and TP53 mutations defines an aggressive subgroup of Ewing Sarcoma, Cancer Discov.
- Trochet, 2005, PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome, Am. J. Hum. Genet., 76, 421, 10.1086/428366 · DOI · Paper page
- Walkley, 2008, Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease, Genes Dev., 22, 1662, 10.1101/gad.1656808 · DOI · Paper page
- Weiss, 1997, Targeted expression of MYCN causes neuroblastoma in transgenic mice, EMBO J., 16, 2985, 10.1093/emboj/16.11.2985 · DOI · Paper page
- Whiteman, 1997, Risk factors for childhood melanoma in Queensland, Australia, Int. J. Cancer, 70, 26, 10.1002/(SICI)1097-0215(19970106)70:1<26::AID-IJC4>3.0.CO;2-8 · DOI · Paper page
- Williamson, 2010, Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma, J. Clin. Oncol., 28, 2151, 10.1200/JCO.2009.26.3814 · DOI · Paper page
- Wong, 2013, Incidence of childhood and adolescent melanoma in the United States: 1973-2009, Pediatrics, 131, 846, 10.1542/peds.2012-2520 · DOI · Paper page
- Zhang, 2012, A novel retinoblastoma therapy from genomic and epigenetic analyses, Nature, 481, 329, 10.1038/nature10733 · DOI · Paper page
- Zhu, 2012, Activated ALK collaborates with MYCN in neuroblastoma pathogenesis, Cancer Cell, 21, 362, 10.1016/j.ccr.2012.02.010 · DOI · Paper page
Cited by
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Gryder, B. E., Yohe, M. E., Chou, H.-C., Zhang, X., Marques, J., Wachtel, M., Schaefer, B., Sen, N., Song, Y., Gualtieri, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1297 · Cited by 316
Orthotopic patient-derived xenografts of paediatric solid tumours
Stewart, E., Federico, S. M., Chen, X., Shelat, A. A., Bradley, C., Gordon, B., Karlstrom, A., Twarog, N. R., Clay, M. R., Bahrami, A., et al. (2017) · Nature · doi:10.1038/nature23647 · Cited by 286
Self-citationThe Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis
Aldiri, I., Xu, B., Wang, L., Chen, X., Hiler, D., Griffiths, L., Valentine, M., Shirinifard, A., Thiagarajan, S., Sablauer, A., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.022 · Cited by 262
Self-citationRoberts, R. D., Lizardo, M. M., Reed, D. R., Hingorani, P., Glover, J., Allen‐Rhoades, W., Fan, T., Khanna, C., Sweet‐Cordero, E. A., Cash, T., et al. (2019) · Cancer · doi:10.1002/cncr.32351 · Cited by 127
Fan, T. M., Roberts, R. D., & Lizardo, M. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00013 · Cited by 90
Metadata
- Authors
- Stewart, E., Federico, S., Karlstrom, A., Shelat, A., Sablauer, A., Pappo, A., & Dyer, M. A.
- Venue
- Developmental Biology
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 411
- Issue
- 2
- Pages
- 287-293
- ISSN
- 0012-1606 (ISSN-L)
- OpenAlex
- W2030873686
- Cited by
- 79
- References
- 7
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- NCI (CA21765)
- NIH (EY014867, EY018599, CA168875)
- the American Lebanese Syrian Associated Charities (ALSAC)
- Alex's Lemonade Stand Foundation for Childhood Cancer
- HHMI
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. https://app.cochat.ai/papers/10.1016/j.ydbio.2015.03.001
- The paper
- Stewart, E., Federico, S., Karlstrom, A., Shelat, A., Sablauer, A., Pappo, A., & Dyer, M. A. (2016). The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. Developmental Biology. https://doi.org/10.1016/j.ydbio.2015.03.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.